Doc's note: There's no magic key to help you unlock consistent gains. Even the world's best investors don't get it right every time.

But, as Whitney Tilson explains, there are ways you can give yourself a leg up in the markets...

For the first dozen years that I ran my own hedge fund, I crushed the market – nearly tripling my investors' money in a flat market...

Along the way, my assets under management grew from $1 million to $200 million. And I made a lot of money for myself, too.

I don't tell you this to brag. I'll be the first to admit I made several big mistakes along the way. My experiences – both big successes and major mistakes – have taught me exactly what works in investing... and what doesn't.

So today, I'll share three of the simplest and most important lessons I've learned and explain how you can apply them immediately to improve your investing results.

Lesson No. 1: Do Your Own Research

First up: Beware of speculating, avoid the hottest sectors, and think independently...

It's important to understand that investing and speculating are at different ends of the spectrum.

Investing involves looking for the rare "needle in the haystack" – a stock or other asset that can be purchased for far less than its intrinsic value.

To find such investments, you generally need to research a company and its industry in depth... and then develop an investment thesis rooted in knowledgeable analysis.

Speculating involves none of that. You have no idea what something is really worth. Instead, you buy something hoping to get lucky by having someone even more foolish buy it from you at a higher price. This is gambling, not investing.

The first key to making big money in the markets is avoiding big losses. And the surest way to lose a lot of money quickly (and never make it back) is to get sucked into the hottest sectors, which are invariably bubbles.

That's how folks who bought cannabis company Tilray Brands (TLRY) near a split-adjusted $2,000 per share back in September 2018 ended up losing a fortune. Today, Tilray shares trade for around $4.

If you're buying what everyone else is buying, what are the odds that you've found something undervalued? Just about zero.

While piling in to whatever's hot can be costly, you shouldn't necessarily limit yourself to stocks and sectors that are hated.

One of the mistakes I made early in my career was avoiding companies unless they were truly out of favor. But some insanely great companies never really fell out of favor. For example, consider search-engine titan Alphabet (GOOGL), which has risen from a split-adjusted $2.51 per share in mid-2004 to more than $300 today.

Investing isn't just about following momentum or being a contrarian... It's about thinking independently. Don't worry about whether you're standing with the crowd on any stock. Do the research, come to your own conclusions, and stick to your guns.

Lesson No. 2: Don't Be Afraid to Be Greedy

Next, you've got to let your winners run...

There's an old saying on Wall Street that cautions against greed: "Pigs get fat, hogs get slaughtered."

I disagree.

If you're looking in the right places for high-quality businesses whose stocks are attractively priced, every once in a while, you're going to invest in a stock that doesn't just double... but goes up 5, 10, 50, or even 100 times.

To build a successful long-term track record, you must be greedy when opportunities like this arise! Investing in a moonshot stock only happens maybe once a decade – or even once in a lifetime. So it's critical that you make the maximum amount of money on them.

In my nearly two decades on Wall Street, I owned a handful of moonshot stocks, including Amazon (AMZN), Apple (AAPL), and – most painfully – Netflix (NFLX).

When I bought the stock in 2012, Netflix was deeply out of favor. But I saw a business with a product customers loved that was more than 10 times bigger than its nearest competitor... and still growing like a weed. Sure enough, shares soon took off. Two years later, the stock was up 600%.

I could have sat back and watched my profit grow for years after correctly identifying one of the greatest stocks of all time. Instead, I sold half of my shares once the stock doubled. Then, I sold some more shares when it doubled again. And as the stock was doubling a third time, I got out of the position completely.

I thought I was being conservative and managing my risk. But in reality, I was shooting myself in the foot. If I had simply held on to my original position in Netflix, I would've made about 10 times more. It was a costly mistake.

That's not to say you shouldn't ever sell a stock that's working for you. It's important to control position sizes to manage risk, of course. And it's even more important to be attuned to fundamental changes in the story.

Lesson No. 3: Focus on the Fundamentals

To be successful in investing, you must also tune out the noise and focus on fundamentals...

I've made tens of millions of dollars over the years with my favorite type of investment: a good stock with strong fundamentals that falls after difficulties in the business. Once the company fixes its problems, the stock often rallies strongly.

A classic example is fast-food chain McDonald's (MCD), which did all sorts of dumb things in the years leading up to 2003. It engaged in a price war with Burger King... built too many stores... and focused its marketing on lower-priced, lower-margin Dollar Menu items.

The stock got clobbered, falling 70% from 1999 to 2003. But the company's operating cash flows were only down 15%. That kind of discrepancy is exactly what investors like me look for.

I invested 5% of my fund in McDonald's shares at the end of 2002. A few months later, when the stock had fallen even further, I backed up the truck and made it a 10% position. The stock soon doubled and kept climbing to become a multibagger.

That big gain wasn't about luck. I knew McDonald's had become undervalued, and I was rewarded when the market agreed with me. Following a good process doesn't always lead to a good result, but it does improve the odds.

The three lessons I've shared today will help you become a much better long-term investor. Put them to work today.

Best regards,

Whitney Tilson

Editor's note: Last week, Whitney detailed the dramatic shift that is coming to stocks and why he's expecting multiple 1,000% wins... as big-name AI stocks fall behind. He also shared exactly where to move your money. Click here to learn more.

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top